NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market today that its third quarter revenues were up 13 percent year over year to $27.0 million from $23.9 million in Q3 2016.

In a preliminary report last month, the company estimated that it would end up with between $25.9 million and $26.9 million in total revenues for the third quarter of 2017, including product and service revenue of approximately $16.9 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.